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	ABSTRACT 
The Effects of Acute Photobiomodulation on Anaerobic Exercise Performance 
Jillian Forsey 
Optimal performance in sport requires a balance between training stress and 
recovery. Therapeutic modalities that allow athletes to maintain this balance while 
training hard are in high demand, but many lack research. Photobiomodulation is a red 
and near-infrared light therapy that is proposed to enhance exercise performance and 
hasten recovery. The purpose of this study was to examine the effects of acute whole 
body photobiomodulation, applied pre-exercise, on anaerobic exercise performance. 
Forty-eight healthy, active subjects participated in this single-blind, crossover 
study. Subjects visited the lab three times to complete a repeat Wingate test, with one 
week between each visit. All subjects completed baseline testing during their first visit 
and randomly received either the photobiomodulation or placebo condition before testing 
on the second visit, followed by the opposite condition on the third visit.  
There was a significantly higher peak power on the first Wingate test following 
photobiomodulation (p=0.046) but no differences in peak power on the second, third, and 
fourth Wingate tests. There was also a significantly higher power drop on the first 
Wingate test (p=0.045) but no differences on the second, third, and fourth Wingate tests. 
There were no differences in average power on any of the Wingate tests. Blood lactate 
was significantly lower following photobiomodulation, before exercise (p=0.0001), 
trending higher after the first Wingate test (p=0.077), and significantly higher after the 
second Wingate test (p=0.048). Peak heart rate was significantly higher following 
photobiomodulation on the first (p=0.009), second (p=0.022), and fourth (p=0.015) 
Wingate tests. On the day following photobiomodulation, heart rate variability was 
higher (p=0.0043) but there were no differences in subjective recovery and stress scores.  
Based on these findings, we concluded that acute photobiomodulation may 
enhance maximal anaerobic performance but does not attenuate fatigue. We also 
concluded that acute photobiomodulation may enhance recovery from maximal, 
anaerobic exercise.  
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CHAPTER 1: INTRODUCTION 
1.1 Background and Significance 
Sport is an integral part of culture worldwide. While moderate to vigorous 
physical activity is necessary for health and longevity, sport serves a wider purpose 
(1,2,98). Sport connects communities and countries through shared interest and common 
goals. Sport has evolved significantly over the past 40 years with improving media 
coverage that provides access to a global audience (98). During this time period, federal 
governments put more money into development of sport in order to compete on the 
international stage, contributing to sportive nationalism (98). This is evident through the 
development of training and recovery centers such as the US Olympic Training Centre 
and the Australian Institute of Sport, that aim to produce some of the top athletes in the 
world (51,101,102).  
Optimal performance in sport requires a balance between training stress and 
adequate recovery (95). Thus; in order to be their best, athletes must train and recover as 
efficiently as possible. To enhance their training and performance, athletes often use 
strategies such as hydration, nutrition, supplements, and therapeutic modalities to help 
delay the onset of fatigue (17,18,19,36).
Recovery is just as important as training, particularly because athletes are training 
at a higher volume than ever (97). In order to balance this high training stress, recovery 
strategies must also evolve. Elite training centers value recovery just as much as training, 
and often provide mobile recovery modalities that travel with their athletes to the 
Olympics and other major competitions (51). While adoption of modern recovery 
modalities by athletes is high, the research is still limited (3). Although elite coaches have 
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stated that they want more research to back up the recovery modalities that they are 
using, they continue to use unproven methods at a high rate (52). Popular recovery 
modalities among athletes include cold water immersion or cryotherapy, compression 
garments, massage therapy, electrostimulation, and photobiomodulation (3,33).
Photobiomodulation is a red and near-infrared light therapy that uses light-
emitting diodes, lasers, or a combination of both, to apply light at wavelengths ranging 
between 600 and 1100 nm (4,5). Light in this wavelength range penetrates the skin and is 
absorbed by the mitochondria, where it speeds up cellular processes (specific 
mechanisms discussed in section 2.8 below) (6). This promising modality has been used 
for many years in medical settings to decrease inflammation, increase tissue repair, and 
apply analgesia (5,41). In the last two decades, there has been an increased use of 
photobiomodulation in sport settings (4). Pre-exercise, photobiomodulation may be used 
to enhance performance in aerobic events by improving time to exhaustion and VO2 
kinetics (59,60,61,75,78). In anaerobic events, photobiomodulation can improve force 
produced and fatigue index (69,73,74,81,82). Photobiomodulation can also be used as a 
recovery modality when applied pre- or post-exercise by attenuating increases in muscle 
damage and oxidative stress markers such as creatine kinase (CK), lactate dehydrogenase 
(LDH), protein carbonyls, and thiobarbituric acid-reactive substances (TBARS) 
(60,69,73,74,75,82,83,84,96). However, the vast majority of the research on 
photobiomodulation in sport settings has been done with custom made LED arrays 
generally targeting a single muscle group. For this research, this application is termed 
“targeted photobiomodulation”. Thus, there is very limited research on the use of whole 
body photobiomodulation. Due to the promising findings of targeted photobiomodulation 
	 3	
in previous literature, and the adoption of whole body devices by professional and 
collegiate sport teams, there is a significant need for research on the efficacy of whole 
body photobiomodulation as a performance enhancing and recovery modality.  
1.2 Purpose and Specific Aims 
 The purpose of this study was to examine the effects of acute whole body 
photobiomodulation, applied pre-exercise, on anaerobic exercise performance. We 
hypothesized that acute photobiomodulation would enhance performance in an anaerobic 
exercise test by increasing peak power and average power and decreasing power 
decrement. We also hypothesized that acute photobiomodulation would attenuate the 
increase in blood lactate and increase work output, as defined through an increase in heart 
rate throughout the exercise test. Finally, we hypothesized that acute photobiomodulation 
would hasten the recovery process and result in lower blood lactate and resting heart rate 
and higher heart rate variability at 10 minutes post-exercise test, as well as decreased 
recovery and stress scores and increased heart rate recovery in the days following. 
Specific Aim 1: To determine the effect of acute photobiomodulation on performance 
during an acute, maximal, anaerobic exercise test. 
Hypothesis 1: Acute photobiomodulation will improve power dynamics achieved in a 
repeat Wingate test. 
Hypothesis 2: Acute photobiomodulation will decrease blood lactate before, during, and 
following a repeat Wingate test. 
Hypothesis 3: Acute photobiomodulation will increase work output, as defined by a 
higher heart rate during a repeat Wingate test. 
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Specific Aim 2: To determine the effect of photobiomodulation on recovery from an 
acute, maximal, anaerobic exercise test. 
Hypothesis 1: Acute photobiomodulation will increase heart rate variability before and 
after a repeat Wingate test. 
Hypothesis 2: Acute photobiomodulation will decrease stress and recovery scores on the 
day following treatment. 
Hypothesis 3: Acute photobiomodulation will increase heart rate variability on the day 
following treatment.  
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CHAPTER 2: LITERATURE REVIEW 
2.1 Fatigue and performance 
 Muscular fatigue is defined as the inability to maintain muscular contractile force 
for a period of time. It is developed through maximal exercise or sub-maximal exercise 
performed for a prolonged time period (8,10,14,15,21,34,37). Muscular fatigue typically 
affects muscular strength and motor control, and often causes some level of pain (10). 
The time of onset of fatigue is affected by fitness level, muscle fiber type, and intensity, 
type, and duration of exercise (34,37). However, if the individual is exercising at a high 
enough intensity, or for a long enough time, they will experience muscular fatigue at 
some point (10,34,37). Muscular fatigue is different from muscle damage because it is 
more easily reversible and may be considered a protective mechanism to prevent 
structural muscle damage from occurring (21). Management of fatigue is particularly 
relevant for athletes because an increase in muscular fatigue will increase risk of injury 
and decrease performance (16). Because of this, a significant amount of research has 
been dedicated to determining how to delay this fatigue response.  
 Fatigue can be quantified using a fatigue index, which measures resistance to 
fatigue. The fatigue index may measure the drop in peak force, torque, or power of 
muscle contraction (37). There are a number of tests that can measure fatigue resistance. 
An isokinetic dynamometer may be used to test the number of maximal effort repetitions 
before either exhaustion or a 50% reduction in torque output is reached (37). Another 
common test is the Wingate test, which assesses the difference between the peak and 
lowest power outputs during a 30-second maximal cycling bout (37, 38). It is common 
among both elite and recreational athletes to employ methods to improve their fatigue 
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index, or delay the onset of fatigue. These methods include hydration strategies, nutrition, 
supplements such as creatine and arginine, and therapeutic modalities such as 
photobiomodulation (10,17,18,19,36). 
2.2 Mechanisms of muscular fatigue 
 Muscle fatigue can stem from a number of points in the motor pathway. 
Peripheral fatigue occurs due to changes in processes at or distal to the neuromuscular 
junction while central fatigue occurs at the central nervous system and decreases 
signaling to the muscle (10,21,100). Metabolic factors have a significant effect on 
peripheral fatigue. When muscle contracts, ATPases and glycolysis are activated, leading 
to increased levels of H+, lactate, inorganic phosphate (Pi), and reactive oxygen species 
(ROS). Accumulation of these metabolites interferes with cross-bridge cycling, thus 
affecting the muscle’s ability to produce force (100). Pyruvate is a byproduct of 
glycolysis that feeds into the citric acid cycle for oxidation. When pyruvate cannot be 
oxidized as quickly as it is being produced, it gets converted into lactic acid, which is 
further broken down into lactate and H+. As H+ accumulates, pH decreases and ATP is 
depleted (21,100). This process affects the release of Ca2+ from the sarcoplasmic 
reticulum, sensitivity of troponin C to Ca2+, and cross-bridge cycling (100). Furthermore, 
creatine phosphate is hydrolyzed to creatine and Pi. Pi accumulation can decrease release 
of Ca2+ from the sarcoplasmic reticulum, leading to a deleterious effect on activation 
(21,100). Increasing exercise intensity also leads to increased production of reactive 
oxygen species (ROS) (100). This increase in ROS leads to an increase in oxidation of 
proteins, lipids, and nucleic acids as well as a decrease in antioxidant capacity (21). This 
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oxidation of cell proteins then inhibits Ca2+ release from the sarcoplasmic reticulum and 
decreases myofibrillar Ca2+ sensitivity (100).  
2.3 Biomarkers related to fatigue 
2.3.1 Lactate 
 One of the most commonly measured biomarkers to assess fatigue is blood lactate 
(35,100). Blood lactate is often used because it correlates well with increasing exercise 
intensity and is unrelated to age, sex, and physical fitness (100). Normal resting blood 
lactate levels generally fall in the 0.5-1.5 mM range, with 4 mM considered the onset of 
blood lactate accumulation (35). At exercise intensities above 50-60% of maximal 
aerobic capacity, there is an increase in blood lactate, with levels typically ranging from 
10-20 mM (34). However, maximal intermittent exercise can produce higher blood 
lactate levels than continuous exercise, with values ranging up to 25 mM (34,35). This 
increase in blood lactate during high intensity exercise is because ATP production, 
through oxidative phosphorylation of ADP, cannot meet the energy requirement of the 
myocyte, so there is a shift in ATP production from aerobic processes to anaerobic 
processes (21). The anaerobic breakdown of carbohydrates creates lactic acid, which is 
broken down into lactate and hydrogen ions, causing acidosis. This debilitates muscle 
function by impairing calcium handling, decreasing metabolic enzyme activity, and 
inhibiting myosin ATPase (37,66,67). The lactic acid hypothesis states that, as lactate is 
accumulated at the working muscle, contractile processes are inhibited, directly or 
indirectly through metabolism, and there is a decline in exercise performance (37,39). 
This hypothesis is supported by Messonier et al. (40), who found a strong correlation 
between pH levels and work capacity during supramaximal exercise in humans. Because 
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of the relation to fatigue, blood lactate monitoring is a common tool used in planning 
training programs in high-level sports (36). 
 
Figure 1. Blood lactate kinetics during exercise (20). 
2.3.2 Reactive Oxygen Species (ROS) 
 When reactive oxygen species (ROS) are not reduced by antioxidants at the same 
rate at which they are produced by oxidation, oxidative stress occurs (13,24). Research 
has shown a correlation between ROS and decreased muscle function and the 
development of muscle fatigue (13,25,60). This correlation may be due to the excess 
electron held by ROS, which causes fatigue and damage to mitochondria (21). Effects of 
ROS on muscle function include a decrease in the sarcolemma’s ability to depolarize, 
impaired calcium release and sensitivity, decreased actin-myosin interactions, inhibition 
of enzymes, and restriction of blood flow (21). Two enzymes that defend against 
oxidative stress are superoxide dismutase (SOD) and catalase (CAT) (62). SOD catalyzes 
a redox reaction to convert superoxide (O2-) to molecular oxygen (O2) and hydrogen 
peroxide (H2O2) (62). Catalase (CAT) catalyzes the decomposition of H2O2 to water and 
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oxygen (21). Common biomarkers to examine oxidative stress include damage markers 
thiobarbituric acid-reactive substances (TBARS) and protein carbonyls, and antioxidant 
capacity markers SOD, CAT, glutathione (GSH), and total antioxidant capacity (TAC) 
(21). Following prolonged or maximal exercise, there is typically an increase in TBARS, 
protein carbonyls, SOD, CAT, GSH, and TAC but even short-duration, submaximal 
exercise can induce increases in SOD and TAC (64,65). 
 
Figure 2. Demonstrates the effects of acidosis and ROS as they relate to muscle fatigue 
(37). 
2.3.3 Inflammatory Biomarkers 
 Muscle contraction during exercise causes a protective inflammatory reaction, 
inducing a release of pro- and anti-inflammatory cytokines (21,63). This response is 
typically related to muscle damage that is fatiguing and contributes to delayed onset 
muscle soreness in the days following damaging exercise (69). This muscle damage 
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promotes a marked increase in pro-inflammatory cytokines Tumor Necrosis Factor-alpha 
(TNF-α) and interleukin-1 beta (IL-1β); interleukin-6 (IL-6), which acts as both a pro- 
and anti-inflammatory cytokine; cytokine inhibitors IL-1 receptor antagonist (IL-1ra) and 
TNF soluble receptors (sTNF-r1 and sTNF-r2); and anti-inflammatory cytokine 
interleukin-10 (IL-10) (63).  
 
Figure 3. The interaction between exercise and cytokines (20). 
2.4 Recovery and Performance 
 Optimal recovery following an intense training session or competition is essential 
to an athlete’s performance (95). This is because rate of recovery from one session affects 
the effort an athlete is able to give in subsequent training sessions and competitions 
(51,52). If training stress is not balanced with adequate recovery, an athlete will 
experience under-recovery. As fatigue accumulates, this athlete becomes at risk for 
developing overreaching and overtraining, the latter of which can take months to years to 
recover from (95). There are different subjective and objective measures that can be taken 
into account when quantifying recovery status, which are detailed below. 
2.5 Markers of recovery 
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2.5.1 Delayed Onset Muscle Soreness (DOMS) 
 A common measure of recovery status is delayed onset muscle soreness (DOMS). 
DOMS refers to exercise-induced muscle injury that is characterized by muscle pain, 
decreased maximal muscle strength, and increased serum creatine kinase (CK) 
(28,30,31,32). DOMS typically peaks 24-48 hours after exercise and subsides within 5-7 
days (30,31). DOMS most frequently occurs following unfamiliar exercise, most often at 
the beginning of a training season, or exercise that involves a significant amount of 
eccentric contractions (28,30,31).  
2.5.2 Creatine Kinase (CK) 
 Creatine Kinase (CK) is an enzyme present most abundantly in skeletal muscle, 
myocardium, and the brain. Hypoxia or injury causes release of CK into the circulation, 
thus CK has long been used as a marker of myocardial infarction; but can also be used as 
a marker of muscle damage (68). During exercise, the sarcolemma is disrupted, allowing 
CK to travel in the extracellular fluid, through the lymphatic system, and to the 
circulation (70). CK is an ideal muscle damage marker to measure because it has a 
substantial increase from baseline in response to exercise, is fairly inexpensive to 
measure, and can be measured effectively through capillary or venous samples (71,72). 
McLellan et al. (72) found that CK was elevated within 30 minutes of a competitive 
Rugby League match and still hadn’t returned to baseline five days following the match, 
concluding that CK is a valuable monitoring tool for determining recovery status in 
athletes. 
2.5.3 Subjective Wellness 
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 Another common index of recovery is subjective wellness. Subjective wellness 
refers to perceived feelings of fatigue by an athlete and may be a better indicator of 
readiness and recovery than objective measures (46). There are a number of validated 
questionnaires that are used to measure subjective wellness. One of the most commonly 
used questionnaires is the Recovery-Stress Questionnaire for Athletes (RESTQ-Sport), 
designed to measure how physically and/or mentally stressed an individual is (51). In a 
study examining the use of the RESTQ-Sport with professional football players, Laux et 
al. (47) found a significant relationship between the Fatigue, Sleep Quality, Disturbed 
Breaks, and Injury scales on the RESTQ-Sport and subsequent athlete injuries. They 
concluded that the RESTQ-Sport could effectively be used throughout the season to 
predict and prevent future injuries. The downside of the RESTQ-Sport is that it is a 
lengthy questionnaire, comprised of 77 items, which may be difficult to implement on a 
regular basis (51). Similarly, the Profile of Mood States (POMS) assesses the effect of 
training on mood and affective states (51). Kentta et al. (53) found that using the POMS 
during intense training periods in elite kayakers may allow them to avoid overreached 
and stale states. Like the RESTQ-Sport, the POMS is a longer questionnaire, with 65 
items, and may be difficult to use consistently (51).  
  Fortunately, there are shorter subjective wellness questionnaires that have been 
validated and may be easier to use on a frequent basis. The Acute Recovery and Stress 
Scale (ARSS) and the Short Recovery and Stress Scale (SRSS) were developed by 
Hitzschke and colleagues (48,54,55) to efficiently measure recovery and stress status in 
athletes. The ARSS consists of 32 items whereas the SRSS consists of just 8 items to 
allow for frequent monitoring (56). These questionnaires were originally developed in 
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German but have since been translated and validated for English populations, with 
recovery and stress scores that correlate with those of the RESTQ-Sport (48,56). Flynn 
and colleagues (57) validated the SRSS during in-season volleyball training and found 
that the SRSS was an effective tool for monitoring recovery and stress states. 
 To measure an athlete’s perceived effort during a single training session, Borg’s 
Rating of Perceived Exertion (RPE) scale is a one-dimensional scale that asks individuals 
to rate their exertion on a scale of 6-20 (52). Borg’s RPE scale has been validated and 
RPE strongly correlates to blood lactate and heart rate values, making this a credible 
measure of perceived effort during a single session (58). 
2.5.4 Heart Rate Variability (HRV)  
 Recovery can also be monitored through resting heart rate (HR) and heart rate 
variability (HRV). Traditionally, resting HR has been used as a marker of recovery, with 
increased resting HR suggesting central nervous system fatigue and potential 
overreaching and low resting HR considered a sign of recovery (42,43). This relationship 
is dependent on the inotropic and chronotropic effects of the autonomic nervous system 
(ANS) (42,44). However, the problem with resting HR as a measure of recovery is that 
the changes are fairly minimal, usually only changing a few beats per minute, and can be 
influenced by other environmental factors (42,45). Heart rate variability is another 
marker of autonomic tone that may provide a better indication of recovery status than 
resting HR (42,43,44). HRV measures the time variation between two heart beats, 
referred to as the R-R interval. The most commonly used index of HRV is RMSSD, 
which is calculated as the root mean square successive difference between all consecutive 
R-R intervals and the number of contiguous R-R intervals with a difference greater than 
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50 ms, within the collection period (45). RMSSD is a time-domain measurement and is 
more influenced by the parasympathetic system than the sympathetic system (110). HRV 
can also be observed through frequency-domain measurements that estimate power 
distribution in four frequency bands (110). These bands include high frequency (HF), low 
frequency (LF), very low frequency (VLF), and ultra low frequency (ULF) bands (110). 
The HF band is influenced by respiration from 9-24 bpm, LF band by respiration of 3-9 
bpm and rhythm periods from 7-25 seconds, and VLF band by rhythm periods from 25-
300 seconds (110). The LF/HF ratio is often used to estimate the ratio of sympathetic to 
parasympathetic activity (110). Total power may be used as an HRV index during short-
term recordings by summing the VLF, LF, and HF bands (110). Although HRV can also 
be affected by environmental factors, it is considered a better marker than HR because 
even when heart rate is consistent, HRV may show significant changes in beat to beat 
variation (45). Plews et al. (43) found that when monitoring elite triathletes for non-
functional overreaching, HRV was a more sensitive marker than resting HR. From a 
broad health and wellness perspective, high HRV (generally RMSSD) is associated with 
high fitness levels (i.e.VO2 max values) whereas low HRV is associated with increased 
mortality (45). HRV is individual so examining a person’s deviation from their own 
baseline is the most effective way to evaluate HRV as an indicator of ANS status (43). 
HRV measurements taken upon awakening have shown to have a stronger correlation to 
nonfunctional overreaching than HRV measurements taken overnight, so when 
monitoring for chronic fatigue, morning HRV measurements are most beneficial (49). 
Due to individual differences and environmental factors, to adequately use HRV as a 
monitoring tool for fatigue and nonfunctional overreaching, HRV should be measured on 
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a consistent basis, at the same time of day, and under the same conditions (43). HRV may 
also be lowered following intense exercise due to activation of the sympathetic nervous 
system, and remain lowered for up to 24 hours (42,50).  
2.6 Recovery Modalities 
 Recovery modalities can be used by everyone from recreational to elite athletes 
between training sessions to hasten their recovery from one training session or 
competitive event, thus preparing them for the next. The goal of recovery modalities is 
typically to decrease delayed onset muscle soreness, attenuate fatigue, and increase rate 
of lactate removal from the blood (3,33). Traditional recovery modalities include 
stretching, massage therapy, active recovery, and cold-water immersion (3). Currently, 
there is a wave of modern recovery modalities entering the market, such as cryotherapy, 
float therapy, compression garments, electrostimulation, and photobiomodulation (3,33). 
Athletes are quick to embrace these modalities, with the idea that quicker recovery allows 
them to train more and see greater improvements (51,52). However, in a survey of elite 
level coaches of Summer Olympic sports, a significant number of coaches stated that they 
would like to see more research on the effectiveness of these recovery modalities (52). 
This is because although interest in and adoption of these modalities is high, there is still 
limited or conflicting research proving the efficacy of many of these modalities (3,33). 
Massage therapy has shown to provide significant improvements to muscle soreness and 
perceived fatigue, compression and cold-water immersion have shown smaller but still 
significant positive effects, but there is limited research showing the other modalities to 
be effective (3,33). There is not yet any research on the efficacy of whole body 
photobiomodulation as a recovery modality. 
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2.7 Photobiomodulation Therapy 
 Photobiomodulation is also known as low level laser therapy (LLLT) or light 
emitting diode therapy (LEDT) (4). Photobiomodulation is administered through lasers, 
light-emitting diodes, or some combination of the two (4,5,22,41,93). 
Photobiomodulation consists of red and near-infrared light therapy that applies light at 
wavelengths ranging from 600-1100 nm, most typically 660 and 850 nm, with a power 
density ranging from 1 mw-5 W/cm2 (4,5,41). The output power is low enough that it 
does not cause any heating of tissue, thus there is no structural change (5,41). The ideal 
dose is 20-60 J for small muscle groups and 120-300 J for large muscle groups (93). 
Although lasers have greater coherency and smaller spectral bandwidths with less 
divergence of light beams than LEDs, both methods provide the same effects to tissue as 
long as the dose is delivered according to the biphasic dose-response (41). 
 There are a variety of reported benefits of photobiomodulation, many of which 
that can be applied to both sports performance and medical use. Some of these uses 
include decreasing inflammation, increasing tissue repair, and applying analgesia (5,41).  
 When administered pre-exercise, photobiomodulation is proposed to act as a 
performance enhancer through increased force produced and delayed fatigue response 
(10,12,13). When administered pre-exercise, it may also act as a preventative measure 
against muscle damage during exercise (10,12,13). Acutely, photobiomodulation can be 
administered five minutes to six hours prior to exercise, but studies defining this window 
more precisely are lacking. For chronic effects in conjunction with strength or aerobic 
training, photobiomodulation is more effective when administered immediately before 
exercise (93). Photobiomodulation has also been studied as a recovery modality 
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employed post-exercise to decrease muscle damage and enhance recovery processes 
(26,27,28,29). These effects have been examined in both animal and human models. 
2.8 Proposed Mechanism of Photobiomodulation 
 The red and near-infrared light administered during photobiomodulation therapy 
lies within the wavelength range that can transmit through the skin and tissues with 
minimal photon absorption and reach the mitochondria, where it is absorbed, all without 
the carcinogens and mutagens associated with ultraviolet light (6). Within the 
mitochondria, photobiomodulation increases activity of complexes I, II, III, IV, and 
succinate dehydrogenase. However, complex IV, also known as Cytochrome C Oxidase, 
is believed to act as the primary photoacceptor (5,6,7,22,23). Cytochrome C Oxidase is 
the terminal enzyme in the electron transport chain. Here, photobiomodulation increases 
electron availability for reduction of molecular Oxygen to water. This action increases 
the mitochondrial membrane potential, adenosine triphosphate (ATP) production, cyclic 
adenosine monophosphate (cAMP), and protection against reactive oxygen species 
(ROS) (5,41). Ferraresi et al. (9) tested this theory in C2C12 myotubes, a mouse myoblast 
cell line in vitro, and found that photobiomodulation applied to these cull cultures 
increased mitochondrial membrane potential and synthesis of ATP. Based on this data, it 
was concluded that photobiomodulation applied to muscle before exercise could result in 
improved exercise performance. 
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Figure 4. Mechanistic visual of the absorption of red and near-infrared light by cellular 
chromophores in the mitochondrial respiratory chain (41). 
 
2.9 Photobiomodulation Therapy in Animal Models  
2.9.1 Pre-exercise 
 In animal models, photobiomodulation has effectively reduced fatigue and 
decreased muscle damage when applied pre-exercise (10,12,13). Lopes-Martins et al. 
(10) and Leal Junior et al. (12) followed similar protocols by developing muscle fatigue 
in rats with induced tetanic contractions by electrical stimulation. These protocols 
administered photobiomodulation immediately before the first contraction and measured 
subsequent performance. Both groups found that when the rats received 
photobiomodulation treatment immediately before, peak force produced on the final 
contraction and mean performed work on the final contraction were significantly higher. 
Silva et al. (13) used a different protocol by inducing muscle fatigue through forced high-
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intensity treadmill running and delivering photobiomodulation for three consecutive days 
prior to the treadmill task. These data suggested that in the photobiomodulation group, 
there was a significant improvement in time to exhaustion. 
 When photobiomodulation was administered pre-exercise, as a performance 
enhancer, it was also assessed as a recovery tool (10,12,13). Lopes-Martins et al. (10) 
examined plasma creatine kinase (CK) whereas Leal Junior et al. (12) looked at both 
plasma CK and lactate. Both teams found significantly lower CK levels following 
photobiomodulation as compared to the control and Leal Junior et al. (12) found 
significantly smaller changes in lactate as well (10). Silva et al. (13) looked at a broader 
scope of biomarkers of oxidative stress and muscle damage by measuring serum CK, 
protein carbonyls, and superoxide dismutase (SOD). Twenty-four hours following the 
protocol, the photobiomodulation group had significantly lower CK, protein carbonyls, 
and SOD as compared to the control group. The photobiomodulation group presented 
values that were comparable to baseline for all three biomarkers, showing that 
photobiomodulation may be effective at reducing oxidative stress in response to exercise. 
2.9.2 Post-exercise 
 In animal studies where photobiomodulation was employed as a recovery 
modality post-exercise or following muscle injury, the focus was muscle damage markers 
and/or inflammatory markers (26,28,29,32). Although the protocols for these studies 
varied greatly, there were similar findings that could be of interest to athletic populations. 
Multiple studies found that photobiomodulation attenuated increases in serum CK as 
compared to a control (26,28,32). Both Liu et al. (28) and Sussai et al. (32) induced 
muscle damage in rats, with forced downhill running and swimming, respectively, and 
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found that at 24 and 48 hours post exercise, the group that received high dose 
photobiomodulation immediately after exercise had significantly lower serum CK levels 
than an exercise control. Furthermore, Liu et al. (28) found that the serum CK levels of 
the exercise group that received high dose photobiomodulation were not significantly 
different from those of the sedentary control. Liu et al. (28) also found that the high dose 
photobiomodulation group had significantly higher muscle SOD activity and significantly 
lower muscle MDA than the exercise control. Several studies also found that 
photobiomodulation attenuated the inflammatory response as compared to a control 
(26,28,29). Lui et al. (28) found an attenuated degree of inflammatory cell infiltrate in the 
gastrocnemius muscle in the photobiomodulation groups as compared to the control. 
Almeida et al. (29) compared the effects of photobiomodulation (to cryotherapy, 
diclofenac, and a control) on inflammatory cytokine levels following acute skeletal 
muscle injury. This group found that the group that received photobiomodulation had 
significantly lower levels of interleukin-1β, interleukin-6, and tumor necrosis factor-alpha 
than all three other groups. 
2.10 Photobiomodulation Therapy in Human Models  
2.10.1 Pre- aerobic exercise 
 In human models, promising findings for the use of targeted photobiomodulation 
as a performance enhancer in aerobic events have been noted (59,60,61,75,78). Several 
studies have used similar progressive-intensity running protocols and found a beneficial 
effect of photobiomodulation on time to exhaustion and VO2max (59,60,61). Miranda et 
al. (59) also found increased distance covered and decreased dyspnea following 
photobiomodulation. Mezzaroba et al. found higher peak velocity, lower maximum heart 
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rate and lower blood lactate at 13-15 minutes following photobiomodulation, as well 
(61). There have been similar findings in studies involving elite or competitive athletes 
(75,78). In a case study on an elite, female runner performing constant-load high-
intensity running, Ferraresi et al. (75) found improvements in VO2max kinetics, time to 
exhaustion, and O2 deficit following photobiomodulation as compared to the placebo. 
Meanwhile, Lanferdini et al. (78) found that photobiomodulation effectively increased 
time to exhaustion in competitive cyclists. However, not all studies were this promising. 
Junior et al. (77) found a tendency towards increased time to exhaustion in an 
incremental treadmill test following photobiomodulation, but their findings were not 
significant. Beltrame et al. (76) found no statistical differences between 
photobiomodulation and placebo groups on VO2 kinetics or blood lactate during maximal 
incremental cycle ergometer exercise. Machado et al. (79) employed photobiomodulation 
between two 40-minute running time trials that were separated by six hours and found 
there were no significant differences on performance in the second time trial or blood 
lactate. These discrepancies in findings may have to do with methodology or differences 
in photobiomodulation dose, and thus prompt the need for more performance-based 
research. 
 When photobiomodulation is administered pre-exercise, it has an effect on the 
recovery period, as well. Many studies that looked at the aerobic performance effects of 
pre-exercise photobiomodulation also looked at changes in muscle damage, oxidative 
stress, and recovery markers (60,75,79). De Marchi et al. (60) found attenuated increases 
in TBARS, protein carbonyls, CK, and LDH and increases in SOD activity in the 
photobiomodulation group as compared to the control. Ferraresi et al. (75) found lower 
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lactate, CK, and alanine levels in the elite runner following the photobiomodulation trial. 
Similar to their findings on performance, Machado et al. (79) found no differences in CK 
or HRV in the photobiomodulation trial, although there was a moderate effect size for 
attenuated DOMS. 
2.10.2 Pre- anaerobic exercise 
 There has also been substantial research on the effects of photobiomodulation on 
anaerobic performance and, much like the literature on aerobic performance, there are 
promising but mixed findings (36,69,73,74,80,81,83,93). A common protocol that is used 
is an eccentric contraction fatiguing protocol followed by a maximal voluntary 
contraction (MVC) test to determine fatigue index (69,73,74). Three separate studies 
have found an improvement in performance following photobiomodulation, with subjects 
reaching a higher peak torque on the MVC than when they received the placebo 
(69,73,74). Similar studies have examined pre-match or pre-training photobiomodulation 
in team sports that can be highly anaerobic (81,82,93). Dornelles et al. (81) found that 
when photobiomodulation was given to soccer players before a simulated soccer match, 
there was an attenuation in loss of hamstring peak torque, hamstring to quadricep torque 
ratio, and countermovement jump height. This finding was important, as hamstring 
injuries are common in soccer players, and often caused by fatigue. Thus, the attenuation 
in hamstring fatigue could indicate photobiomodulation as a promising preventative 
measure against injury. Pinto et al. (82) examined the use of photobiomodulation with 
high-level rugby players, utilizing a common field test, the Bangsbo Sprint Test. These 
researchers found a significant improvement in sprint time and fatigue index and 
attenuation in blood lactate changes and perceived fatigue, as compared to the placebo 
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condition. De Marchi et al. (93) looked at photobiomodulation applied 40 minutes before 
a professional futsal match and found that players stayed on the pitch for a significantly 
longer period of time and had significantly lower blood lactate pre, immediately post, and 
48 hours post in the photobiomodulation trial as compared to the placebo trial. There 
were also studies that found no significant effects of photobiomodulation on anaerobic 
performance (36,80,96). Dos Reis et al. (36) administered photobiomodulation before a 
maximal knee extension exercise and found no difference in number of reps or duration 
of fatigue between the photobiomodulation and placebo groups. However, this study 
differed from other studies that used the eccentric contraction fatiguing protocol. Dos 
Reis et al. (36) used their fatiguing protocol as the performance assessment rather than 
having subjects complete an MVC test post-fatigue, as we’ve seen in previous literature 
(69,73,74). This discrepancy may explain the differing findings. Orsatto et al. (80) 
developed a protocol that induced fatigue with repeated bilateral countermovement jumps 
(CMJ) and assessed performance and fatigue with a CMJ test, echo intensity, and muscle 
soreness. These researchers found no significant differences between pre-exercise 
photobiomodulation and placebo trials for any of their measures. However, these 
researchers randomly selected one leg to receive photobiomodulation and one leg to 
receive the placebo for each participant, rather than having separate photobiomodulation 
and placebo trials, which may have affected their results. Leal Junior et al. (96) applied 
photobiomodulation or a placebo condition to male soccer and volleyball athletes before 
they performed a Wingate test and found no differences between groups for work 
performed or blood lactate at 3 and 10 minutes post exercise. However, at 15 minutes 
post exercise, blood lactate was significantly lower in the photobiomodulation group.  
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 Photobiomodulation before anaerobic exercise also influences muscle damage, 
oxidative stress, and recovery markers. Following anaerobic exercise, pre-exercise 
photobiomodulation caused a decrease or attenuated increase in CK, LDH, and IL-6, in 
comparison to a placebo (69,73,74,82,94,96). Oleivera et al. (73) and De Marchi et al. 
(94) also found decreases in TBARS and carbonylated proteins following 
photobiomodulation as compared to the placebo. Furthermore, Oleivera et al. (73) found 
decreases in TNF-α and no differences in IL-1β, CAT, or SOD, following 
photobiomodulation.  The effect on muscle soreness is inconclusive as Oleivera et al. 
found a decrease in DOMS following photobiomodulation whereas Baroni et al. and 
Vanin et al. found no difference between groups (69,73,74).  
2.10.3 Post-exercise 
 Photobiomodulation can also be used post-exercise solely as a recovery modality 
to attenuate muscle damage and loss of performance on proceeding days. Several 
researchers have compared the effects of photobiomodulation and cryotherapy following 
damaging exercise (83,84). De Marchi et al. (83) and de Paiva et al. (84) followed similar 
protocols in which a damaging eccentric exercise was performed before receiving 
treatment of either photobiomodulation (PBM), photobiomodulation followed by 
cryotherapy (PBM+CRY), cryotherapy alone (CRY), cryotherapy followed by 
photobiomodulation (CRY+PBM), or a placebo. In both studies, PBM significantly 
attenuated loss of MVC peak torque, increases in DOMS, and increases in CK at 24, 48, 
72, and 96 hours post-exercise. PBM+CRY had lower but still significant, positive effects 
on all three measures while CRY by itself had similar effects to the placebo. The results 
of these studies suggest that photobiomodulation is an effective recovery modality but its 
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efficacy may be decreased by the addition of cryotherapy. Similarly, Borges et al. (85) 
found that photobiomodulation administered following an eccentric contraction protocol 
attenuated loss of muscle strength, loss of range of motion, and increased muscle 
soreness at 24, 48, 72, and 96 hours post-exercise. Although dos Reis et al. (36) found no 
significant effects for pre-exercise photobiomodulation, in the same study, they found 
decreases in lactate and CK following damaging exercise when photobiomodulation was 
administered post-exercise.  However, not all findings were this positive. Malta et al. (86) 
conducted research comparing photobiomodulation (PBM), cold-water immersion 
(CWI), active recovery (AR), and placebo following a repeat Wingate test. These 
researchers found no significant effects on blood markers, DOMS, or CMJ performance 
for any of the recovery modalities at any time points. 
2.10.4 Chronic Photobiomodulation therapy associated with training 
 Photobiomodulation can also affect performance when used in conjunction with 
training over a period of time (87,88,90,91). Viera et al. (88) found that in a 9-week cycle 
ergometer training program, the training group that received photobiomodulation 
following each training session had an improved fatigue index at the end of the study, as 
compared to the sedentary control and just training groups. Paolillo et al. (87) conducted 
a unique study in which subjects received photobiomodulation for 45 minutes twice a 
week for six months while they performed running training on a treadmill. This group 
was compared to a group performing the same training without photobiomodulation and a 
sedentary group. These researchers found improved time to exhaustion, METs, Bruce 
stage, heart rate, and RPE in both the photobiomodulation group and the exercise group 
but the differences in time to exhaustion, METs, and heart rate were significantly greater 
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in the photobiomodulation group. The photobiomodulation group also experienced a 
decrease in time to recovery. One issue with this study is the lack of placebo condition. 
The light was very visible when administered during training so subjects were keenly 
aware of which group they were in. In another aerobic training study, Peserico et al. (92) 
found that when subjects performed a 5-km training program for 8 weeks and received 
either photobiomodulation or a placebo before each training session, there were no 
significant differences between groups for peak velocity or 5-km time at the end of the 
training period. There was a possibly positive effect of photobiomodulation on peak 
velocity and 5-km time when using a magnitude-based inference analysis, so further 
research in this area should be conducted.  
 Several studies also examined photobiomodulation in conjunction with a strength-
training program, but the results were mixed (89,90,91). Vanin et al. (90) separated 
subjects into four groups- photobiomodulation before training and placebo after, placebo 
before training and photobiomodulation after, photobiomodulation before and after 
training, and placebo before and after training. The group that received 
photobiomodulation before training and placebo after, had significantly greater 
improvements in MVC, leg press 1RM, and leg extension 1 RM, following 12 weeks of 
strength training, as compared to the other three groups. This finding suggests that the 
best moment to apply photobiomodulation to a strength-training program is pre-exercise. 
However, Almeida et al. (89) conducted a study in which participants received 
photobiomodulation or a placebo condition prior to strength training twice a week for 
eight weeks, and there were no differences between groups for muscle strength, 
functional performance, or quality of life. Cunha et al. (91) compared 
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photobiomodulation and neuromuscular electrical stimulation (NMES) applied during an 
eight-week training program for muscle strength and jumping skills. Although there was 
an increase in non-dominant lower limb strength in the photobiomodulation group 
compared to the control, NMES was more effective, with significant increases in both 
dominant and non-dominant lower limb strength, as well as global perceived effort, as 
compared to the control.    
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CHAPTER 3: METHODS 
Experimental Approach: A randomized, single-blind, placebo-controlled, crossover 
design was used to examine the effect of photobiomodulation therapy on exercise 
performance in a repeat Wingate test. Order of photobiomodulation condition and 
placebo condition was randomized using a random number generator in Microsoft Excel 
software.  
 
Subjects: Sample size determination was conducted with respect to only the primary aim. 
Variables of interest included differences between photobiomodulation and placebo with 
regards to: peak power, average power, and power decrement (fatigue index); blood 
lactate; and peak heart rate. Due to four comparisons being made, 80% power is achieved 
with 48 volunteers when significance level is 0.05/4 = 0.0125 and Cohen’s d is set to a 
medium effect of 0.5. The individuals were recruited from local running, triathlon, and 
crossfit training groups in Morgantown, WV and surrounding area through Facebook 
groups, email lists, and word of mouth. Subjects were selected to participate in the study 
if they were considered “low risk” by the ACSM Risk Stratification and met ACSM’s 
minimum physical activity guidelines of at least 75 minutes of vigorous or 150 minutes 
of moderate aerobic activity per week.   
Table 1. Participant Characteristics. Data shown are mean ± standard deviation. 
 N=48; F=30, M=18 
Age (years) 34.65 (±12.04) 
Weight (kg) 70.04 (±12.58) 
Height (cm) 170.22 (±9.89) 
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Body Fat Percentage (%) 19.76 (±7.37) 
 
Procedures: Each volunteer had three visits to the laboratory, with each visit separated by 
a seven-day washout period. Each visit occurred on the same day of the week at the same 
time of day. The temperature inside the photobiomodulation room stayed within a range 
of ~80°F to ~85°F and the average temperature inside the testing room was ~70°F to 
~74°F. The first visit consisted of familiarization of procedures, completion of 
questionnaires, anthropometric measurements, and baseline testing. During 
familiarization of procedures, participants received a verbal description of the 
expectations of them for the duration of the study and the events that would take place 
during each visit. Participants were instructed to keep their diet, activity level, and sleep 
habits consistent throughout the duration of the study. 
 
Photobiomodulation:  Photobiomodulation was administered using the Novathor Whole 
Body Light Pod. This device delivers light at wavelengths of 660 and 850 nm with a 
power density of 25 mW/cm2. For the photobiomodulation condition, 
photobiomodulation was administered for 20 minutes immediately before the repeat 
Wingate test was performed. While in the bed, participants wore a blindfold and noise-
cancelling headphones. 
 
Placebo Condition: For the placebo condition, participants laid in the Novathor Whole 
Body Light Pod for 20 minutes with the device switched off, immediately before the 
repeat Wingate test was performed. Space heaters and a fan were turned on to maintain 
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the temperature in the same range of ~80°F to ~85°F that was reached during the 
photobiomodulation condition. Participants wore a blindfold and noise-cancelling 
headphones during both conditions to block out as much light and noise generated by the 
device as possible. 
 
Questionnaires: During the initial visit, participants were instructed to complete three 
questionnaires at their own pace. In order to complete the questionnaires, subjects were 
asked to download the Smartabase application on their smartphone. These questionnaires 
included the Pittsburgh Sleep Quality Index (PSQI), GRIT scale, and Competitive State 
Anxiety Inventory- 2 Revised (CSAI-2R).103,104,105 These questionnaires were selected to 
determine sleep quality of participants before beginning the study, individual differences 
in levels of grit, and levels of competitive state anxiety that may pertain to performance 
in the exercise test administered throughout this study, respectively. Participants were 
also asked to complete two questionnaires each day for the duration of the study. The 
daily questionnaires consisted of the Short Recovery and Stress Scale (SRSS) 
questionnaire and the End of Day Questionnaire.55 The SRSS questionnaire was 
completed each morning upon waking and consisted of eight scales pertaining to the 
participants’ current states of recovery and stress. The purpose of this questionnaire was 
to determine whether the individual’s stress level was consistent throughout the study and 
whether there was a difference in stress level following the first and second testing 
sessions. The End of Day questionnaire was completed each night before bed and was 
used to record the participants’ daily training and nutrition rating. The purpose of this 
questionnaire was to determine whether participants maintained fairly consistent levels of 
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activity and similar dietary habits throughout the duration of the study. The purpose of 
examining homogeneity of stress, sleep, exercise, and diet habits throughout the study 
was to look for any outside factors that may affect a participant’s performance in the 
exercise tests. Upon completion of the study, participants completed an exit questionnaire 
asking them to describe any differences they felt between conditions 
(photobiomodulation and placebo) to determine whether they could tell when they were 
receiving the photobiomodulation condition. This questionnaire also asked whether 
participants maintained consistent diet, sleep, and training habits throughout the study so 
that we could look for potential explanations for any inconsistencies in results. 
 
Daily Heart Rate Variability (HRV): Participant HRV was tracked throughout the 
duration of the study using the Oura ring.106 The Oura is a commercially available sleep 
device with the form factor of a ring, and gives information on sleep quantity and quality, 
as well as heart rate, heart rate variability (RMSSD), and body temperature. This 
technology was selected due to high data quality as assessed in an internal validation 
study (publication in preparation) as well as ease of use to the participant. During the 
initial visit, participants downloaded the Oura ring application on their smartphone and 
were sized for a ring using the Oura ring sizing kit. Participants were given a short 
tutorial on how to navigate the application, how to wear the ring, and when to wear the 
ring. Participants were instructed to wear the ring on the same finger each night with the 
sensor on the palmer side of the hand. Participants were instructed to put the ring on 
before going to bed and to wear it overnight. Upon awakening, participants were 
instructed to complete a 5-minute “Check Body Status” Moment in the application to 
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measure heart rate variability (RMSSD). During the Moment, participants were told to lie 
as still as possible. Following the Moment, participants were instructed to remove the 
ring and leave it on the charging base during the day.  
 
Anthropometric measurements:  Height, weight, and body fat percentage was determined 
for each participant during the initial visit. Height was measured using a Healthometer 
professional scale and weight was measured using a Welch Allen Scaletronix scale. Body 
fat percentage was measured with Lange skinfold calipers using the 7-site skinfold 
method. Each site was measured two times and an average of the two was recorded. The 
same study personnel measured each participant to remove any chance of poor inter-rater 
reliability.  
 
Testing Day Heart Rate Variability: During the initial visit, HRV was measured 
immediately before the exercise test and ten minutes following completion of the last 
Wingate test. During the second and third visits, HRV was measured immediately before 
the exercise test, which fell immediately following reception of either the placebo or 
photobiomodulation condition, and ten minutes following completion of the last Wingate 
test. Heart rate variability was measured using a Polar heart rate strap and the Firstbeat 
Sports application on a smartphone. The sensors on the heart rate strap were moistened 
with OneStep Clear gel and the strap was placed just below the sternum. The participant 
was instructed to lie in a prone position on the turf track for 3 minutes while heart rate 
variability was measured with the Quick Recovery Test in the Firstbeat Sports 
application.  
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Repeat Wingate Test: The exercise test used to assess performance was a repeat Wingate 
test. This test was performed on the Monark 894E Wingate Testing Bike Ergometer. Seat 
height was determined based on hip height and affirmed by visual inspection of leg in a 
fully extended position. Participants were instructed to warm up for five minutes on the 
cycle ergometer at a self-selected pace, against no resistance. After cycling for 5 minutes, 
participants were instructed to accelerate to their maximum speed and then hit a button on 
the right handlebar, causing the weight to drop. The weight was set at 7.5% of the 
participant’s body weight.109 Once the weight dropped, participants cycled at maximal 
effort for 30 seconds. During the 30-second bout, participants were verbally encouraged 
at a consistent rate by the study personnel and were told when they had 15 and 5 seconds 
remaining. Following the 30-second bout, the weight was lifted and the participants 
cycled at an easy, self-selected pace against no resistance for two minutes. Immediately 
after the two-minute recovery period, participants sped up and started the next Wingate 
test. The participants did this a total of four times. Following the fourth and final 30-
second bout, participants were instructed to stay on the bike and cycle at an easy, self-
selected pace for five minutes followed by five minutes of easy walking on the turf track. 
 
Heart Rate: To measure heart rate (HR), participants wore a Polar heart rate strap that 
was connected to the Firstbeat Sports application and collected heart rate data from the 
start of the warm-up until ten minutes following the final Wingate. The sensors on the 
heart rate strap were moistened with OneStep Clear gel and the strap was placed just 
below the sternum. HR was recorded manually by study personnel immediately before 
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starting the warm-up, within five seconds of completion of the first Wingate test, within 
five seconds of completion of the second Wingate test, within five seconds of completion 
of the third Wingate test, within five seconds of completion of the fourth Wingate test, 
and at ten minutes following completion of the fourth Wingate test.  
 
Rating of Perceived Exertion: The Borg Rating of Perceived Exertion Scale (RPE) was 
used to measure participants’ subjective perceived exertion. It was explained to 
participants that the RPE scale was a 6-20 scale, with 6 correlating to no exertion at all 
and 20 correlating to their maximum exertion. To help the participants gain a better 
understanding of these numbers, it was explained that 6-7 was similar to laying on the 
couch, 11-12 was similar to going for a light walk, 15-16 was similar to going for a run, 
and 18-19 was similar to the end of a race when running as hard as possible. Subjects 
were asked to provide their RPE immediately before starting the test, within five seconds 
of completion of the first Wingate test, within five seconds of completion of the second 
Wingate test, within five seconds of completion of the third Wingate test, within five 
seconds of completion of the fourth Wingate test, and at ten minutes following 
completion of the fourth Wingate test. These values were recorded by study personnel. 
 
Blood Lactate: Lactate was measured using a Nova Biomedical Lactate Plus meter, 
Lactate Plus meter test strips, and Unistik 3 Comfort single-use 28-gauge 1.8 mm lancets. 
To test lactate, a test strip was inserted into the Lactate Plus meter, with the logo side up 
and gold side down. The index, middle, or ring finger was prepared for puncture by 
cleaning the tip with an alcohol swab and drying with gauze. To perform the finger prick, 
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the cap was twisted off the lancet, the lancet was placed against the pad of the finger, the 
release button was pressed, and the lancet was removed from the finger. The end of the 
test strip was placed to the blood until the test strip well was full and the test meter 
beeped. The result was provided in thirteen seconds and recorded manually by study 
personnel. Blood lactate was measured immediately before starting the warm-up, within 
thirty seconds of completion of the first Wingate test, within thirty seconds of completion 
of the second Wingate test, within thirty seconds of completion of the third Wingate test, 
within thirty seconds of completion of the fourth Wingate test, and at ten minutes 
following completion of the fourth Wingate test. The Nova Biomedical Lactate Plus 
meter was tested for quality control once a week using the Nova Lactate Plus level 1 and 
level 2 control solutions.  
 
Power Dynamics: Power dynamics were assessed during each individual Wingate test. 
Power dynamics were calculated by the Monark Anaerobic Test Software. During the 
repeat Wingate test, peak power, average power, and power decrement were measured 
for each of four individual Wingate tests, allowing for observation of power dynamics for 
an individual Wingate test as well as changes in power dynamics across the four Wingate 
tests. Power dynamics were calculated unscaled as well as scaled for body weight. No 
power data was collected during warm-up, recovery periods, or cool-down. 
 
Data analysis: All analyses were conducted using R software version 3.6.2. To 
investigate the effect of photobiomodulation with respect to the two aims listed in the 
introduction, two-way repeated measures ANOVAs were constructed using Condition 
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(PBM/Placebo), Time, and the Condition:Time interaction effect. Thus, the repeated 
measures model is of the form: 𝑌!"# = µ+  !(!) +  ! +  ! + (  )!" +  !"# 
In the above equation, 𝑌!"# represents the observation at the kth time point from the ith 
subject in group j (PBM or Placebo group),  ! represents the main effect of Condition, 
 ! represents the main effect of time, (  )!" represents the interaction effect of 
Condition and Time,  !(!) represents the nested effect of subject within Condition (since 
subjects will have different baselines for Lactate, HR, Peak Power, etc.), and  !"# 
represents the error term. This allowed for the examination of both the main effect of 
PBM, as well as the effect of PBM across each individual time point. For Condition, the 
null and alternative hypotheses can be arranged as follows: 
H0: µPBM = µPlacebo, or equivalently,  𝑷𝑩𝑴 =  𝑷𝒍𝒂𝒄𝒆𝒃𝒐 
HA: µPBM ≠ µPlacebo, or equivalently,  𝑷𝑩𝑴 ≠  𝑷𝒍𝒂𝒄𝒆𝒃𝒐 
For the interaction the hypotheses would be: 
H0: (  )𝒋𝒌 are equal for all levels of j (PBM/Placebo) and k (Time points) 
HA: some inequality in (  )𝒋𝒌 
Following the Repeated Measures ANOVA, post-hoc tests were conducted by first 
calculating the matched pair differences between PBM and Placebo at each time point, 
followed by a paired t-test with the following hypotheses:  
H0: µdk = 0 
Ha: µdk ≠ 0, where µdk represents the average paired difference between PBM and 
Placebo at time point k. 
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The power analysis for each aim was conducted with a medium Cohen d effect size of 0.5 
(medium effect), and a significance level of 0.05. Thus, any p-value less than 0.05 was 
considered statistically significant.  	
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CHAPTER 4: RESULTS 
The effects of acute photobiomodulation on power dynamics 
 A primary goal of this study was to determine the effect of acute, pre-exercise 
photobiomodulation on performance in an anaerobic exercise test. One question of 
interest within this study was to examine the differences in power dynamics during a 
repeat Wingate test. In the photobiomodulation trial, there was a significantly higher peak 
power achieved on the first Wingate test (p=0.046), but no differences in peak power on 
the second (p=0.887), third (p=0.544), or fourth (p=0.207) Wingate tests. There was also 
a significantly higher drop in power during the first Wingate test (p=0.045) following the 
photobiomodulation condition, with no differences for drop in power on the second 
(p=0.187), third (p=0.858), or fourth (p=0.118) Wingate tests (Figure 5, Tables 2,3,4). 
There was no difference in average power between conditions. There was a strong, 
positive correlation between the peak power achieved on the first Wingate test and the 
decrement in power during that test (Figure 6).  
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Figure 5. *p<0.05. PP= peak power, AP= average power, PD= power decrement, 
PBM=photobiomodulation. Comparison of unscaled and scaled power dynamics across 
all four Wingate tests between photobiomodulation and placebo conditions. Y-axes 
represent unscaled [W] and scaled for bodyweight [W/s/kg] power dynamics. X-axes 
represent Wingate 1, 2, 3, and 4 in the repeat Wingate test. 
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Figure 6. Comparison of scaled peak power and scaled power decrement on the first 
Wingate test. 
 
Table 2. Minimum (Min.), Median, Mean, Maximum (Max.), and Standard Deviation 
(SD) for scaled [W/kg] peak power (PP) for photobiomodulation (PBM) and placebo 
trials in a repeat Wingate test (W1, W2, W3, W4). 
Variable Min. Median Mean Max. SD 
W1 PBM 
Scaled PP 
(W/kg) 
4.85 8.25 8.766 13.52 1.761	
 
W2 PBM 
Scaled PP 
(W/kg) 
4.32	
 
7.805	
 
7.886	
 
12.12	
 
1.312	
 
W3 PBM 
Scaled PP 
(W/kg) 
5.24	
 
7.425	
 
7.352	
 
10.72	
 
1.186	
 
W4 PBM 
Scaled PP 
(W/kg) 
4.91	
 
7.235	
 
7.258	
 
10.99	
 
1.259	
 
W1 Placebo 
Scaled PP 
(W/kg) 
4.75	
 
8.215	
 
8.599	
 
13.21	
 
1.709	
 
W2 Placebo 5.17	 7.78	 7.903	 10.83	 1.179	
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Scaled PP 
(W/kg) 
     
W3 Placebo 
Scaled PP 
(W/kg) 
4.84	
 
7.165	
 
7.419	
 
9.96	
 
1.139	
 
W4 Placebo 
Scaled PP 
(W/kg) 
4.08	
 
6.955	
 
7.131	
 
10.02	
 
1.152	
 
 
Table 3. Minimum (Min.), Median, Mean, Maximum (Max.), and Standard Deviation 
(SD) for scaled [W/kg] average power (AP) for photobiomodulation (PBM) and placebo 
trials in a repeat Wingate test (W1, W2, W3, W4). 
Variable Min. Median Mean Max. SD 
W1 PBM 
Scaled AP 
(W/kg) 
4.16	
 
6.53	
 
6.659	
 
8.76	
 
1.072	
 
W2 PBM 
Scaled AP 
(W/kg) 
3.26	
 
5.735	
 
5.78	
 
8.32	
 
0.854	
 
W3 PBM 
Scaled AP 
(W/kg) 
3.46	
 
5.235	
 
5.303	
 
8.21	
 
0.869	
 
W4 PBM 
Scaled AP 
(W/kg) 
3.59	
 
5.04	
 
5.169	
 
8.2	
 
0.841	
 
W1 Placebo 
Scaled AP 
(W/kg) 
3.78	
 
6.525	
 
6.614	
 
8.79	
 
1.095	
 
W2 Placebo 
Scaled AP 
(W/kg) 
3.79	
 
5.75	
 
5.833	
 
8.27	
 
0.826	
 
W3 Placebo 
Scaled AP 
(W/kg) 
3.34	
 
5.12	
 
5.303	
 
8.19	
 
0.848	
 
W4 Placebo 
Scaled AP 
(W/kg) 
3.03	
 
5.025	
 
5.136	
 
8.09	
 
0.857	
 
 
Table 4. Minimum (Min.), Median, Mean, Maximum (Max.), and Standard Deviation 
(SD) for scaled [W/kg] power drop (PD) for photobiomodulation (PBM) and placebo 
trials in a repeat Wingate test (W1, W2, W3, W4). 
 
Variable Min. Median Mean Max. SD 
W1 PBM 
Scaled PD 
(W/kg) 
0.076 0.142	
 
0.154	
 
0.297	
 
0.052	
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W2 PBM 
Scaled PD 
(W/kg) 
0.074	
 
0.14	
 
0.148	
 
0.275	
 
0.045	
 
W3 PBM 
Scaled PD 
(W/kg) 
0.082	
 
0.141	
 
0.144	
 
0.26	
 
0.037	
 
W4 PBM 
Scaled PD 
(W/kg) 
0.081	
 
0.133	
 
0.145	
 
0.283	
 
0.044	
 
W1 Placebo 
Scaled PD 
(W/kg) 
0.068	
 
0.138	
 
0.145	
 
0.263	
 
0.049	
 
W2 Placebo 
Scaled PD 
(W/kg) 
0.057	
 
0.133	
 
0.141	
 
0.247	
 
0.04	
 
W3 Placebo 
Scaled PD 
(W/kg) 
0.077	
 
0.14	
 
0.144	
 
0.23	
 
0.034	
 
W4 Placebo 
Scaled PD 
(W/kg) 
0.073	
 
0.134	
 
0.138	
 
0.218	
 
0.034	
 
 
 
The effect of acute photobiomodulation on blood lactate 
 
 Another question of interest was the effect of photobiomodulation on blood 
lactate levels before, during, and following a repeat Wingate test. There was a significant 
decrease in blood lactate (p=0.0001) following photobiomodulation at rest, prior to 
beginning exercise (Figure 7, Table 5). There was a trend towards higher blood lactate 
level following the first (p=0.077) Wingate test and a significantly higher blood lactate 
level following the second (p=0.048) Wingate test. There were no differences in blood 
lactate between groups following the third and fourth Wingate tests and ten minutes 
following completion of the test. 
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Figure 7. *p<0.05. Lactate AUC= lactate area under the curve, 
PBM=photobiomodulation. Comparison of blood lactate levels between 
photobiomodulation and placebo trials. Y-axis represents blood lactate level. X-axis 
represents time points at which blood lactate was tested. Pre= pre-exercise, W1= 
immediately after first Wingate test, W2= immediately after second Wingate test, W3= 
immediately after third Wingate test, W4= immediately after fourth Wingate test, 10 min 
post= 10 minutes following completion of fourth Wingate test.  
 
Table 5. Minimum (Min), median, mean, maximum (Max), and standard deviation (SD) 
for blood lactate values for photobiomodulation (PBM) and placebo trials at pre-exercise 
(Pre), Wingate 1 (W1), Wingate 2 (W2), Wingate 3 (W3), Wingate 4 (W4), and 10 
minutes following completion of Wingate 4 (10 min post). 
Time Condition Min Median Mean Max SD 
Pre PBM 0.3 1 1.106 2.9 0.495 
Pre Placebo 0.4 1.3 1.485 3.4 0.581 
W1 PBM 2.8 6.2 6.71 11.1 2.059 
W1 Placebo 3.2 6.15 6.317 11.2 1.721 
W2 PBM 5.3 9.6 9.806 15.4 2.753 
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W2 Placebo 2.8 9.05 9.133 15.1 2.555 
W3 PBM 7.9 12.45 12.419 18.5 2.622 
W3 Placebo 7 12.5 12.158 16.5 2.477 
W4 PBM 9.3 13.45 13.604 19.8 2.737 
W4 Placebo 7.4 13.5 13.308 17.5 2.567 
10	min	post	 PBM	 5.8	 11.45	 11.242	 17.1	 2.631	
10	min	post	 Placebo	 5.6	 11.05	 11.065	 16.6	 2.742	
 
The effect of photobiomodulation on peak heart rate 
 Another question of interest was the effect of photobiomodulation on peak heart 
rate during a maximal, anaerobic exercise test. Peak heart rate was significantly higher on 
the first (p=0.009), second (p=0.022), and fourth (p=0.015) Wingate tests following 
photobiomodulation (Figure 8, Table 6). There were no significant differences in peak 
heart rate pre-exercise (p=0.077), on the third Wingate test (p=0.054), or ten minutes 
following completion of the fourth Wingate test (p=0.997). 
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Figure 8. *p<0.05. HR= heart rate, PBM= photobiomodulation. Plot shows the 
comparison of peak heart rate before, during, and after the repeat Wingate test between 
photobiomodulation and placebo trials. Y-axis represents heart rate. X-axis represents 
time points at which heart rate was recorded. Pre= pre-exercise, W1= immediately after 
first Wingate test, W2= immediately after second Wingate test, W3= immediately after 
third Wingate test, W4= immediately after fourth Wingate test, 10 min post= 10 minutes 
following completion of fourth Wingate test. 
 
Table 6. Minimum (Min), median, mean, maximum (Max), and standard deviation (SD) 
for peak heart rate values for photobiomodulation (PBM) and placebo trials at pre-
exercise (Pre), Wingate 1 (W1), Wingate 2 (W2), Wingate 3 (W3), Wingate 4 (W4), and 
10 minutes following completion of Wingate 4 (10 min post). 
Time Condition Min Median Mean Max SD 
Pre PBM 49 74.5 74.062 112 13.062 
W1 PBM 143 165.5 165.521 204 13.066 
W2 PBM 149 168.5 169.042 194 10.735 
W3 PBM 152 170 170.333 192 10.217 
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W4 PBM 152 170 171.312 192 10.492 
10 min post PBM 85 118 117.708 156 17.84 
Pre Placebo 52 68 71.188 98 12.079 
W1 Placebo 107 160.5 161.542 200 15.936 
W2 Placebo 147 166 167.25 195 11.597 
W3 Placebo 150 169 168.938 190 10.381 
W4 Placebo 152 170 169.792 189 10.455 
10 min post Placebo 68 118 116.458 155 18.227 
 
The effect of acute photobiomodulation on rating of perceived exertion  
 
 Another question of interest was the effect of acute photobiomodulation on rating 
of perceived exertion (RPE). There were no differences in RPE between 
photobiomodulation and placebo conditions at any time point (Figure 9). 
 
Figure 9. *p<0.05. RPE= rating of perceived exertion, PBM= photobiomodulation. Plot 
shows the comparison between RPE during photobiomodulation and placebo trials during 
a repeat Wingate test. Y-axis represents RPE. X-axis represents time points at which RPE 
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was recorded. Pre= pre-exercise, W1= immediately after first Wingate test, W2= 
immediately after second Wingate test, W3= immediately after third Wingate test, W4= 
immediately after fourth Wingate test, 10 min post= 10 minutes following completion of 
fourth Wingate test. 
 
The effects of acute photobiomodulation on recovery  
 A secondary goal of this study was to determine the effects of acute 
photobiomodulation on recovery from a repeat Wingate test. One index of recovery that 
was measured was heart rate variability. Heart rate variability was measured following 
the photobiomodulation or placebo condition at rest, before exercise and ten minutes 
following completion of the fourth Wingate test. Following photobiomodulation, prior to 
exercise, RMSSD (p=0.0076), HF average (p=0.013), LF average (p=0.003, and total 
power (p=0.003) were significantly lower. There were no differences in LF/HF (p=0.675) 
or VLF average (p=0.072). Ten minutes following the fourth Wingate test, there were no 
significant differences in any heart rate variability measurements (Figure 10).  
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Figure 10. *p<0.05. PBM=photobiomodulation, HF=high frequency band, LF=low 
frequency band, VLF= very low frequency band, LF/HF=the ratio of low frequency to 
high frequency power. Plots show comparison of heart rate variability measures 
following photobiomodulation or placebo conditions, before exercise. Y-axes represent 
log of each heart rate variability measurement. X-axes represent time point at which heart 
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rate variability was measured. Pre= immediately pre-exercise, Post= 10 minutes 
following completion of fourth Wingate test. 
 
 Recovery was also assessed on the day following the repeat Wingate test. For this 
assessment, we looked at participants who received photobiomodulation or placebo 
condition on the second week as separate groups. We compared changes in heart rate 
variability and Stress and Recovery scores on the day following the repeat Wingate test 
from baseline testing in the first week to either photobiomodulation or placebo condition 
testing in the second week. According to the data, subjects who received 
photobiomodulation in the second week had a significantly higher heart rate variability 
than those who received the placebo (p=0.043) (Figure 11). There were no differences 
between Recovery (p=0.713) or Stress (p=0.978) scores between the two groups (Figure 
12). 
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Figure 11. *p<0.05. PBM= photobiomodulation. Plot shows the comparison between 
heart rate variability from baseline on the morning following the repeat Wingate test to 
the morning following either placebo or photobiomodulation condition and repeat 
Wingate test. Y-axis represents the difference between week two and week one. X-axis 
represents placebo and PBM groups. 
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Figure 12. *p<0.05. Plot shows the comparison between Recovery and Stress scores 
from baseline to placebo or photobiomodulation condition. Y-axis represents the 
difference between recovery and stress scores in week two and week one. X-axis 
represents placebo and PBM groups. 
 
The effectiveness of the placebo condition 
 To determine the effectiveness of the placebo condition, we looked at answers to 
a questionnaire completed following the end of study participation. 58.3% of participants 
stated that they could detect a difference between the conditions (Figure 13). When asked 
to describe the difference, 29% of subjects correctly identified which week they received 
the photobiomodulation condition. 
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Figure 13. Answers to the question of whether participants could detect a difference 
between conditions. Y-axis represents the number of participants who answered. X-axis 
represents the answers, yes or no. 
 
The familiarization effect of the repeat Wingate test on performance and stress and 
recovery scores 
 We also looked at whether there was a familiarization effect of the test that would 
result in changes in performance and stress and recovery scores from the first to second 
week, when photobiomodulation was not a factor. To examine this, we looked at only the 
participants that received the placebo condition on the second week of testing. There was 
a significantly higher peak power on the fourth Wingate test in the second week of testing 
(Figure 14). There was a great amount of variability in stress and recovery scores but no 
significant differences between the two weeks (Figure 15). Heart rate variability was 
significantly lower in week two than week one. Anecdotally, subjects were asked in 
informal interviews whether the test felt harder or easier on the second week and the 
majority of subjects responded that the test felt easier on the second week. 
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Figure 14. *p<0.05. Plot shows comparison of scaled [W/kg] peak power across the 
sequence of four Wingate tests from baseline testing during week one and placebo group 
testing during week two. Y-axis represents scaled peak power [W/kg]. X-axis represents 
Wingate test number.  
 
Table 7. Comparison of peak power across the sequence of four Wingate tests from 
baseline testing during week one and placebo group testing during week two. 
 
Variable Min. Median Mean Max. t p-value 
Wingate 1 -0.98 -0.23 -0.100 2.18 -0.724 0.476 
Wingate 2 -4.92 -0.2 -0.195 2.04 -0.714 0.482 
Wingate 3 -1.53 0.055 0.142 3.84 0.683 0.501 
Wingate 4 -1.08 0.345 0.406 1.98 2.61 0.016 
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Figure 15. *p<0.05. Comparison of stress, recovery, and heart rate variability scores 
following baseline testing in week one and placebo group testing in week two. Y-axis 
represents the difference between week two and week one. X-axis represents scores for 
stress, recovery, and heart rate variability. 
 
Table 8. Comparison of stress, recovery, and heart rate variability Scores following 
baseline testing in week one and placebo group testing in week two. 
 
variable	 Min.	 Median	 Mean	 Max.	 t	 p-value	
Stress	Score	 -8	 -1	 1	 11	 0.927	 0.365	
Recovery	Score	 -8	 -0.5	 0.35	 8	 0.356	 0.726	
Heart	Rate	
Variability	 -66	 -8	 -13.18	 15	 -2.83	 0.014	
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 Study participants were instructed to maintain consistent activity, sleep, and 
dietary habits throughout the study so we looked at the variability in training load and 
recovery and stress scores from questionnaires that the subjects filled out daily. There 
was a large amount of variation in both training load and stress and recovery scores 
within and between subjects (Figures 16-18). 
 
 
Figure 16. Variation in daily training load for each subject during the two-week duration 
of the study 
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Figure 17. Variation in daily stress scores for each subject during the two-week duration 
of the study 
 
 
Figure 18. Variation in daily recovery scores for each student during the two-week 
duration of the study 
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CHAPTER 5: DISCUSSION 
 The purpose of this study was to determine the effects of acute 
photobiomodulation, pre-exercise, on maximal, anaerobic exercise performance. It was 
hypothesized that pre-exercise photobiomodulation would improve power dynamics in a 
repeat Wingate test. We found that on the first Wingate test in a series of four repeat 
Wingate tests, there was an increase in peak power achieved. There was also an increase 
in power decrement on the first Wingate test. The correlation between increased peak 
power and increased power decrement can account for the lack of change in average 
power on the first Wingate test. These results are consistent with the literature on targeted 
photobiomodulation that showed improvements in anaerobic power following acute 
photobiomodulation (69,73,74,81,82). However, the majority of these studies included a 
fatiguing protocol that took place after photobiomodulation and before the anaerobic 
performance assessment (69,73,74,81). Only Pinto et al. (82) examined the effect of 
acute, pre-exercise photobiomodulation on anaerobic performance without any sort of 
fatiguing protocol beforehand, much like the first Wingate test in our series of four 
Wingate tests. Based on the previous literature that showed better anaerobic performance 
following a fatiguing protocol when targeted photobiomodulation was employed pre-
exercise, we expected that we would see better performance on all four Wingate tests in 
the series. We had this expectation because the repeat Wingate test serves as both a 
performance assessment and a fatiguing protocol. Thus, there is a higher degree of 
fatigue for each successive Wingate test. Based on the previous literature, it was expected 
that this fatigue would be attenuated following the photobiomodulation condition. 
Instead, we observed no differences in peak power, average power, or power decrement 
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between conditions on Wingate tests two, three, and four. There are a couple of potential 
explanations. The Wingate test is a 30-second, intense bout of cycling that relies 
primarily on immediate energy from ATP and phosphocreatine from the ATP-PC system 
(111).  These energy compounds become depleted in about 20-30 seconds of maximal 
exercise (111). Based on this knowledge, it is possible that the increased ATP produced 
by the photobiomodulation therapy is depleted during the first Wingate test. Therefore, 
we don’t see continued higher power output on the remaining Wingate tests because that 
ATP has already been depleted. Another potential factor could be due to differences in 
homogeneity among subjects. In the literature, subjects were fairly homogenous. In the 
studies that found improvements in anaerobic performance following a fatiguing 
protocol, subjects were all male and in the 18-36 age range (69,73,74,81). In this study, 
there was an uneven distribution of sex, with 30 females and 18 males; subjects ranged in 
age from 18 to 56; and subjects ranged in body fat percentage from 5.5% to 35.2%. 
Furthermore, despite the instruction to maintain consistent sleep, exercise, and dietary 
habits throughout the duration of the study, there was a large amount of variation in 
training load and stress scores between and within subjects. This subject group allows us 
to examine the effects of photobiomodulation in a broader population than those 
examined in the literature. This is important because although professional or elite 
athletes tend to be fairly homogenous, there are other population groups that are less 
homogenous and still have a need or desire for these types of devices. Therefore, these 
findings may be of interest to populations such as military high performers or recreational 
athletes. Furthermore, because the literature is dominated by male subject groups, our 
	 59	
subject group consisting of both sexes allows us to better apply our findings to the 
population at large.  
 It was also hypothesized that pre-exercise photobiomodulation would decrease 
blood lactate levels before, during, and after a repeat Wingate test.  We found that 
following pre-exercise photobiomodulation, lactate was significantly lower before 
exercise, as expected. There were limited protocols in the literature that tested lactate 
following administration of photobiomodulation and before exercise but our findings 
were consistent with De Marchi et al. (94) who also found a significantly lower blood 
lactate level at this time point as compared to the placebo condition. Following the first 
Wingate test, lactate was trending higher, and following the second Wingate test, lactate 
was significantly higher. There were no examples in the literature that tested lactate 
during exercise. However, lactate increases with increasing workload (20,100). There 
was a higher peak power and peak heart rate achieved on the first Wingate test in the 
photobiomodulation condition, which could explain the higher blood lactate levels 
following the first and second Wingate tests. There were no differences between 
conditions following the third and fourth Wingate tests or ten minutes following the final 
Wingate test. Because there were no differences in power dynamics on the second, third 
and, fourth Wingate tests; it could be expected that lactate levels would even out between 
groups following the third and fourth Wingate tests. It was expected that there would be 
lower blood lactate levels in the photobiomodulation trial at ten minutes following the 
test because the literature consistently showed lower blood lactate levels post-exercise 
when photobiomodulation was administered pre-exercise (36,61,82,93,96). However, the 
higher blood lactate following the first and second Wingate tests may partially explain 
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this finding because lactate was already higher for the photobiomodulation condition and 
had further to drop. Another factor could be the time point at which we tested. Several 
studies found significantly or trending lower lactate levels immediately and ten minutes 
post-exercise, so we expected to see lower lactate at 10 minutes post (36, 82, 93). 
However, there were also several studies that did not find a significant difference until 
later (61,96). Leal Junior et al. (96) found blood lactate to be significantly lower at 15 
minutes post exercise with no difference between photobiomodulation and placebo 
groups at 3 and 10 minutes post-exercise. Similarly, Mezzaroba et al. (61) found blood 
lactate to be significantly lower at 13 and 15 minutes post-exercise, but no difference 
between photobiomodulation and placebo groups at 0, 3, 5, 7, 9, or 11 minutes post-
exercise. If we took a blood lactate measurement at 15 minutes post or another later time 
point, we may have seen more significant results. 
 We also hypothesized that peak heart rate would be higher throughout the repeat 
Wingate test for the photobiomodulation condition. Peak heart rate was significantly 
higher on the first, second, and fourth Wingate tests. This was expected because, much 
like blood lactate, heart rate increases with increasing exercise intensity (107). Therefore, 
as peak power trended higher on the first Wingate, we observed an increase in peak heart 
rate to correlate with the higher workload. There were no significant differences in RPE, 
which is likely due to the nature of the exercise test. Participants were consistently 
reporting very low RPE before the test and near maximal RPE by the end of the test. 
These results are consistent with the findings of Mezzaroba et al. (61). 
 A secondary purpose of this study was to examine the recovery effects of 
photobiomodulation. On testing days, we assessed heart rate variability immediately 
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before exercise at rest and ten minutes following completion of the last Wingate test. 
Following photobiomodulation, before exercise, RMSSD, HF average, LF average, and 
total power were significantly lower. At ten minutes following completion of the last 
Wingate test, there were no differences in any measures of heart rate variability. There 
were no protocols in the literature that measured heart rate variability at these time points. 
We know that heart rate variability is a measure that functions best as an index of 
recovery when tracked consistently over time and is most accurate when assessed in the 
morning (43,45,49). Therefore, it is likely that heart rate variability measurements taken 
immediately pre and post exercise are not good indicators of recovery status. 
  We also assessed recovery on the day following testing by separating the subjects 
into two groups: the group that received photobiomodulation in the second week of the 
study and the group that received the placebo in the second week of the study. The group 
that received photobiomodulation in the second week had a significantly higher heart rate 
variability than the group that received the placebo, when compared to baseline. This 
indicates that photobiomodulation may be an effective recovery tool when used pre-
exercise because higher heart rate variability is indicative of better recovery (42,43,44). 
This is also consistent with the findings of Machado et al. (79), who found an increase in 
heart rate variability 48 hours following photobiomodulation administered between two 
40-minute running time trials. There were no differences in recovery and stress scores 
from baseline. This is likely because these scores can be affected by other factors, such as 
general life stress, and were highly variable throughout the study. There was also a 
significant amount of variability in training load throughout the study. Depending on the 
timing of higher and lower training load days in respect to testing days, this could have 
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been a significant factor when looking at the effect of photobiomodulation as a recovery 
modality.  
 Following completion of the study, participants completed a questionnaire to help 
us understand our findings. One question asked was whether subjects maintained 
consistent activity, sleep, and dietary habits throughout the study. Only 17% of subjects 
replied that these habits were inconsistent. This conflicted with the variability we saw in 
daily training loads and recovery scores. Based on this inconsistency, it is possible that 
participants did not understand the importance of day-to-day consistency. Another 
question we asked was whether participants could detect a difference between the 
conditions they received before testing in weeks two and three. About 58% of subjects 
stated that they could detect a difference between the conditions they received on weeks 
two and three. However, when asked to describe the difference between the conditions 
received, only 29% of subjects correctly identified which week they received 
photobiomodulation. Based on these findings, we determined that our placebo condition 
was effective.  
 We also looked at the familiarization effect of the test by looking at changes in 
power dynamics of those who completed baseline testing the first week and received the 
placebo condition before testing the second week. Within this cohort, there was a 
significantly higher peak power on the fourth Wingate test in the second week. Based on 
these findings, we determined that the subjects were more likely to “save” more energy in 
the beginning of the test in the second week because they had a better understanding of 
how hard the test would feel. By starting more conservatively, they fatigued less and 
were able to reach a higher peak power on the fourth test. In an informal survey 
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following completion of the test on week two, subjects were asked whether it had felt 
harder, easier, or the same as the previous week. Most subjects replied that it felt easier in 
the second week, with many providing reasoning that they felt more mentally prepared. 
The feeling that it was easier in the second week was likely related to the trend towards 
lower peak power on the first and second Wingate tests, even if they were not aware that 
their peak power was lower. This finding is significant because the Wingate test is 
intended to be a true maximal test. Therefore, if subjects are starting more conservatively 
on the first Wingate test and have less fatigue accumulated by the fourth Wingate test, we 
may not be seeing a true picture of how photobiomodulation affects power dynamics in a 
highly fatigued state. There were no significant differences in stress or recovery scores on 
the day following testing between week one and two but heart rate variability was 
trending lower in week two. This lower heart rate variability is not expected based on 
differences in performance on the repeat Wingate test in weeks one and two. It is possible 
that these participants had higher activity levels in the days or week prior to the second 
testing session than the first that may have skewed the results to seem like they were not 
recovering as well from the test on the second week.  
CONCLUSION 
 In conclusion, in a group of healthy, active adults, acute photobiomodulation may 
enhance maximal, anaerobic performance, as observed through increased peak power on 
a Wingate test. Because improvements in peak power were only seen on the first Wingate 
test in a cumulative series of four, we could not conclude that photobiomodulation 
attenuates fatigue, but this area deserves further research. Based on differences in heart 
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rate variability on the day following testing, pre-exercise photobiomodulation may 
enhance recovery.  
LIMITATIONS AND FUTURE DIRECTIONS 
 The main limitation within this study was our inability to test a wide range of 
biomarkers. There were several promising biomarkers of interest tested in the literature; 
including muscle damage markers, reactive oxygen species, and inflammatory markers. 
These biomarkers are most accurate when tested through venipuncture, which is not a 
capability our lab had at the beginning of this study. Furthermore, in the literature, these 
biomarkers were typically tested at several time points up to 72 hours after administration 
of photobiomodulation. Given the high volume of study participants, short time frame for 
this study, and limited study personnel; testing this extensive would not have been 
possible. With increased resources, future research should include testing for muscle 
damage markers, such as CK and LDH; reactive oxygen species, such as CAT, SOD, 
TBARS, and carbonylated proteins; and inflammatory markers, such as TNF-α, IL-6, and 
IL-1β. In the literature, targeted photobiomodulation had an effect on all of these 
biomarkers. We are interested in seeing whether whole body photobiomodulation has 
similar effects on these biomarkers as this will tell us more about the mechanistic effects 
of photobiomodulation. 
 Another limitation of this study was that we only tracked heart rate variability, 
training, and recovery and stress scores for two weeks rather than three. Participants 
returned the Oura rings and stopped completing the questionnaires on the last testing day, 
so we did not have recovery data for the day and week following the final testing session. 
Because of this limitation, when analyzing the recovery effects of photobiomodulation, 
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we had to split the participants into separate groups based on whether they received 
photobiomodulation or placebo in the second week, and compare them to baseline. The 
reasoning behind this decision was concerning resource management and participant 
compliance. However, in reflection, our analysis would have been stronger if we had 
maintained the crossover design for this aspect of the study. While the primary goal of 
this study was to examine the performance effects of acute photobiomodulation, future 
research should focus on the recovery effects by continuing to monitor recovery indices 
for a period following the final testing session. Future research focused on recovery 
should also compare pre and post exercise photobiomodulation to determine which time 
point has the greatest effect on recovery. Because we saw a lower resting blood lactate 
after photobiomodulation, pre-exercise, we are now interested in determining if we see a 
similar effect when photobiomodulation is administered immediately after exercise when 
blood lactate levels are high. 
 Another limitation of this study was the lack of consistency in the training and 
recovery habits of the participants. This lack of consistency likely affected the results 
both in the performance tests and recovery indices. Future research should provide 
stricter guidelines for participants to follow in terms of training and recovery to reduce 
the effect of these factors on study findings. Another limitation in relation to the 
participants was differing experience riding a bike. Some participants were not 
comfortable on a bike and thus had trouble giving a maximal effort, which likely affected 
our results. Future research should use more universal testing methods, such as a 
treadmill test; include more familiarization trials; or use stricter inclusion and exclusion 
criteria to insure that participants have experience on a bike. 
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 We are also interested in future research looking at the effects of chronic 
photobiomodulation. We were interested in the effects of acute photobiomodulation 
because these effects can be related to the use of photobiomodulation pre-competition. 
However, the literature on chronic use of photobiomodulation is not as extensive as the 
literature on acute photobiomodulation. This is an area of interest because it would 
provide valuable information to athletes and sport teams interested in incorporating 
regular photobiomodulation into their training programs.   
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